Lanean...
Heat shock factor 1 confers resistance to lapatinib in ERBB2-positive breast cancer cells
Despite success of ERBB2-targeted therapies such as lapatinib, resistance remains a major clinical concern. Multiple compensatory receptor tyrosine kinase (RTK) pathways are known to contribute to lapatinib resistance. The heterogeneity of these adaptive responses is a significant hurdle for finding...
Gorde:
| Argitaratua izan da: | Cell Death Dis |
|---|---|
| Egile Nagusiak: | , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Nature Publishing Group UK
2018
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5967334/ https://ncbi.nlm.nih.gov/pubmed/29799521 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41419-018-0691-x |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|